NEUROONE MEDICAL TECHNOLOGIE (NMTC) Stock Income Statement
NASDAQ:NMTC - Nasdaq - US64130M2098 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.76M | 3.45M | 3.45M | 2.12M | 240.00K | |||
| Cost Of Goods | 2.63M | 2.37M | 1.50M | 240.00K | 280.00K | |||
| Gross Profit | 6.12M | 1.08M | 1.95M | 1.88M | -30.00K | |||
| Operating Expenses | 12.70M | 12.97M | 13.91M | 11.91M | 10.18M | |||
| Research and Development | 4.99M | 5.07M | 6.94M | 4.93M | 3.93M | |||
| Selling, General, and Administrative Expenses | 7.71M | 7.90M | 6.93M | 6.98M | 6.26M | |||
| Operating Income | -6.58M | -11.89M | -11.96M | -10.03M | -10.22M | |||
| Interest Income/Expense | N/A | -556.10K | N/A | 0.00 | 0.00 | |||
| Other Income/Expense | 80.70K | 125.20K | 95.80K | 30.00K | 270.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -6.61M | -12.32M | -11.86M | -10.00M | -9.95M | |||
| Income Tax | N/A | N/A | 0.00 | N/A | N/A | |||
| Net Income | -6.61M | -12.32M | -11.86M | -10.00M | -9.95M | |||
| EBITDA | -6.32M | -11.64M | -11.76M | -9.91M | -10.14M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.23 | -0.46 | -0.65 | -0.63 | -0.93 | |||
| Non GAAP EPS | N/A | N/A | -0.65 | -0.63 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 69.88% | 31.27% | 56.62% | 88.68% | -12.50% | |||
| Profit Margin | -75.42% | -356.74% | -343.91% | -471.70% | -4145.83% | |||
| Operating Profit Margin | -75.07% | -344.26% | -346.69% | -473.11% | -4258.33% | |||
All data in USD